Christos Fountzilas

Biospecimen Collection

3 trials

phase_1phase_1_2phase_2

Leucovorin Calcium

phase_1_2phase_2

Fluorouracil

phase_1_2phase_2

Laboratory Biomarker Analysis

phase_1_2

Magnetic Resonance Imaging

phase_1phase_1_2

Oxaliplatin

phase_1_2phase_2

Biopsy

1 trial

phase_1

NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial

+14 more interventions

22 unique interventions3 categories

Analytics

Trial Phases

Phase 14

Phase 24

Trial Status

Completed2

Recruiting2

Other2

Role Distribution

Principal Investigator6

PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT06821997Phase 2Recruiting

Borderline Resectable Pancreatic Ductal Adenocarcinoma

PrincipalinvestigatorStart date: 2026-03-02

NCT07214298Phase 1/2Recruiting

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Metastatic Pancreatic Ductal AdenocarcinomaStage IV Pancreatic Cancer AJCC v8

PrincipalinvestigatorStart date: 2026-02-16

NCT02713373Phase 1/2Completed

Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery

Recurrent Colorectal CarcinomaStage IVA Colorectal CancerStage IVB Colorectal Cancer

PrincipalinvestigatorStart date: 2016-08-05

NCT02393755Phase 1/2Completed

Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer

Colon AdenocarcinomaRectal AdenocarcinomaRecurrent Colon Carcinoma+5 more

PrincipalinvestigatorStart date: 2015-05-08

NCT04870034Early Phase 1Withdrawn

Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer

Colorectal CarcinomaLung AdenocarcinomaMalignant Solid Neoplasm+1 more

Principalinvestigator

NCT06206876Phase 1Withdrawn

FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma

Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal Adenocarcinoma+5 more

Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Metastatic Pancreatic Ductal Adenocarcinoma2 Stage IV Pancreatic Cancer AJCC v82 Advanced Pancreatic Ductal Adenocarcinoma1 Borderline Resectable Pancreatic Ductal Adenocarcinoma1 Colon Adenocarcinoma1 Colorectal Cancer1 Locally Advanced Pancreatic Ductal Adenocarcinoma1 Adenocarcinoma of Lung1

Affiliations

Roswell Park Cancer Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xiaoli Lan, PhD

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

16 trials

Shared therapeutic areas:

Colorectal CancerAdenocarcinoma of Lung

Similarity Score3%

Ajay Goel, PhD

City of Hope Medical Center

24 trials

Shared therapeutic areas:

Colorectal CancerPancreatic Carcinoma

Similarity Score3%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

11 trials

Shared therapeutic areas:

Eric FRANCOIS, Dr

Centre Antoine Lacassagne, Nice

4 trials

Shared therapeutic areas:

Jeong Min Lee, MD

Seoul National University Hospital

34 trials

Shared therapeutic areas:

Sabine Hazan, MD

ProgenaBiome

41 trials

Shared therapeutic areas:

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

32 trials

Shared therapeutic areas:

National Cancer Institute (NCI)

Worked with same sponsors:

Jane Robertson, BSc, MBCHB, MD

AstraZeneca

12 trials

Shared therapeutic areas:

David Cunningham

Royal Marsden NHS Foundation Trust

13 trials

Shared therapeutic areas:

Saleh K Saleh, MD

Minia University

23 trials

Shared therapeutic areas: